GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Loans Receivable

LAVA Therapeutics NV (LAVA Therapeutics NV) Loans Receivable : $0.00 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Loans Receivable?

LAVA Therapeutics NV's Loans Receivable for the quarter that ended in Mar. 2024 was $0.00 Mil.


LAVA Therapeutics NV Loans Receivable Historical Data

The historical data trend for LAVA Therapeutics NV's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Therapeutics NV Loans Receivable Chart

LAVA Therapeutics NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
- - - - -

LAVA Therapeutics NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

LAVA Therapeutics NV Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


LAVA Therapeutics NV Loans Receivable Related Terms

Thank you for viewing the detailed overview of LAVA Therapeutics NV's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


LAVA Therapeutics NV (LAVA Therapeutics NV) Business Description

Traded in Other Exchanges
Address
Yalelaan 62, Utrecht, UT, NLD, 3584 CM
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.

LAVA Therapeutics NV (LAVA Therapeutics NV) Headlines

From GuruFocus

LAVA Therapeutics to Participate at the Jefferies Healthcare Conference

By GuruFocusNews GuruFocusNews 07-02-2022

LAVA Therapeutics to Present LAVA-1207 Clinical Data at the 2023 ASCO GU Symposium

By Stock market mentor Stock market mentor 01-23-2023

LAVA Therapeutics Announces Two Appointments to its Board of Directors

By GuruFocusNews GuruFocusNews 07-05-2022